A Phase II Study of Vorinostat (Suberoylanilide Hydroxamic Acid) Plus Rituximab in Indolent Non-Hodgkin's Lymphoma

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/43F0393D.svg?ark=w1%2F20260526%2F43F0393D&value=id)](https://nobleid.org/work/w1/20260526/43F0393D)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors